Atossa Therapeutics News

Atossa Therapeutics | DEL AM: Others

May 14 16:52 ET

Atossa Therapeutics | S-3: Registration statement for specified transactions by certain issuers

May 13 16:10 ET

Atossa Therapeutics | 10-Q: Quarterly report

May 13 09:09 ET

Atossa Therapeutics | 8-K: Atossa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update

May 13 09:04 ET

Atossa Therapeutics | ARS: Annual Report to Security Holders

May 10 09:09 ET

Atossa Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

May 10 09:03 ET

Atossa Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Finn Jonathan

Apr 11 16:06 ET

Atossa Therapeutics | 8-K/A: Current report (Amendment)

Apr 2 14:10 ET

Atossa Therapeutics | 10-K: Annual report

Apr 1 16:09 ET

Atossa Therapeutics | 8-K: Current report

Apr 1 16:03 ET

Atossa Therapeutics | 8-K: Current report

Mar 18 08:39 ET

Atossa Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Cigler Tessa

Mar 14 20:40 ET

Atossa Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Cigler Tessa

Mar 14 20:30 ET

Atossa Therapeutics | 8-K: Current report

Mar 12 08:32 ET

Atossa Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer WEAVER GREGORY L

Nov 17, 2023 16:01 ET

Atossa Therapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Finn Jonathan

Nov 15, 2023 17:03 ET

Atossa Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Finn Jonathan

Nov 15, 2023 16:15 ET

Atossa Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Finn Jonathan

Nov 15, 2023 16:05 ET

Atossa Therapeutics: Q3 2023 Earnings Report

Nov 13, 2023 09:10 ET

Atossa Therapeutics | 8-K: Atossa Therapeutics Announces Third Quarter 2023 Financial Results and Provides Corporate Update

Nov 13, 2023 09:00 ET